journal article·2024-03-11Open access

Development of a system for detecting cardiac troponin I by background fluorescence quenching based on internal filtration effect

Lei Wang, Wei Zhang, Bailing Song, Ziyi Zhang, Jiutong Li, Xinxia Li, Jun Yao

Nanotechnology· Volume 35· Issue 11

Abstract

Abstract The present study sought to develop a cardiac troponin I (cTnI) detection system based on background fluorescence quenching of internal filtration effect (IFE) and study the influence of IFE on the sensitivity of cTnI detection. Three nanogold materials were synthesized as fluorescence quenchers, and rhodamine 6 G (R6G) and Cy5 were used as fluorescence probes. Six experimental systems were established to detect cTnI in negative serum test solutions and clinical serum samples. The sensitivity of each system was compared to explore the contribution of IFE to the detection sensitivity of cTnI. When applied to negative serum test solutions, the R6G-nanogold material I system exhibited a superior detection effect for cTnI, with a limit of detection (LOD) of 0.15 ng ml−1. When applied to clinical serum samples, the Cy5-nanogold material Ⅲ system yielded a better detection effect for cTnI, with the lowest concentration of cTnI detected at 2 ng ml−1. The first and second internal filtering effects in the proposed system can be achieved simultaneously, effectively avoiding light absorption interference from clinical serum samples and enhancing the sensitivity of the background fluorescence quenching detection of cTnI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Acute Myocardial Infarction Research · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Comparison of two-year outcomes of acute myocardial infarction caused by coronary artery spasm versus that caused by coronary atherosclerosis10.1016/j.amjcard.2019.08.019 ↗
2. Analytical characteristics of high-sensitivity cardiac troponin assays10.1373/clinchem.2011.165795 ↗
3. Cardiac troponin I to diagnose myocardial injury10.1016/0140-6736(93)90622-N ↗
4. Screening for cardiovascular disease risk with electrocardiography10.1001/jamainternmed.2018.2773 ↗
5. Troponins and natriuretic peptides in cardio-oncology patients-data from the ECoR registry10.3389/fphar.2020.00740 ↗
6. Evaluation of 99th percentile value of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform10.1016/j.cca.2019.06.018 ↗
7. Highly sensitive chemiluminescence-based lateral flow immunoassay for cardiac troponin I detection in human serum10.3390/s20092593 ↗
8. Design, synthesis, and evaluation of gold nanoparticle-antibody-horseradish peroxidase conjugates for highly sensitive chemiluminescence immunoassay (hs-CLIA)10.1007/s12257-018-0369-3 ↗
9. Optimization of an enzyme linked DNA aptamer assay for cardiac troponin I detection: synchronous multiple sample analysis on an integrated microfluidic platform10.1039/C9AN00779B ↗
10. Ultrasensitive chemiluminescence immunoassay with enhanced precision for the detection of cTnI amplified by acridinium ester-loaded microspheres and internally calibrated by magnetic fluorescent nanoparticles10.1039/D0NR08008J ↗
11. Development of a rapid assay for human cardiac troponin I
12. Establishment of colloid gold immunity chromatography assay for cardiac troponin I (cTnI)
13. Software for simulation of luminescence quenching mechanism: the stern-volmer kinetic model10.5935/0100-4042.20140060 ↗
14. Analysis of fluorescence quenching of new indole derivative by aniline using Stern-Volmer plots10.1016/j.jlumin.2005.02.012 ↗
15. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins10.1016/j.saa.2004.05.028 ↗
16. Study on the interaction between methyl violet and bovineserum albumin by spectral analyses10.1016/j.saa.2009.06.054 ↗
17. Study of the interaction between terazosin and serum albumin synchronous fluorescence determination of terazosin10.1016/S0003-2670(01)01453-2 ↗
18. The binding of 3-(p-bromophenyl)−5-methyl-thiohydantoin with human serum albumin: investigation by fluorescence spectroscopy and molecular model10.1016/j.jlumin.2007.01.022 ↗
19. Real time quantification of intracellular nickel using genetically encoded FRET-based nanosensor10.1016/j.ijbiomac.2019.07.115 ↗
20. A new nanoprobe based on FRET between functional quantum dots and gold nanoparticles for fluoride anion and its applications for biological imaging10.1016/j.bios.2012.04.007 ↗
21. Fluorescence resonance energy transfer analysis of merlin conformational changes10.1128/MCB.00248-09 ↗
22. Using GFP in FRET-based applications10.1016/S0962-8924(98)01434-2 ↗
23. Optically-active nanocrystals for inner filter effect-based fluorescence sensing: Achieving better spectral overlap10.1016/j.trac.2018.11.002 ↗
24. Development of a quantitative detection card for heart-type fatty acid-binding protein based on background fluorescence quenching immune chromatography10.2478/jomb-2018-0017 ↗
25. Electrogenerated chemiluminescence biosensor array for the detection of multiple AMI biomarkers10.1016/j.snb.2017.10.108 ↗
26. High-sensitivity troponins and mortality in the general population10.1093/eurheartj/ehad328 ↗
27. Comparison of high sensitive and conventional troponin assays in diagnosis of acute myocardial infarction10.1515/TJB-2016-0270 ↗
28. Evaluation of analytical performance of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform10.1515/cclm-2017-1101 ↗
29. The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction
30. Novel peptidylated surfaces for interference-free electrochemical detection of cardiac troponin I10.1016/j.bios.2017.08.024 ↗
31. Guidelines for emergency rapid diagnosis and treatment of acute coronary syndrome10.3969/j.issn.1002-1949.2019.04.001 ↗